Abstract
Tumor-associated macrophages (TAM) are prominent components of tumor microenvironment (TME) and capable of promoting cancer progression. However, the mechanisms for the formation of M2-like TAMs remain enigmatic. Here, we show that lactate is a pivotal oncometabolite in the TME that drives macrophage M2-polarization to promote breast cancer proliferation, migration, and angiogenesis. In addition, we identified that the activation of ERK/STAT3, major signaling molecules in the lactate signaling pathway, deepens our molecular understanding of how lactate educates TAMs. Moreover, suppression of ERK/STAT3 signaling diminished tumor growth and angiogenesis by abolishing lactate-induced M2 macrophage polarization. Finally, research data of the natural compound withanolide D provide evidence for ERK/STAT3 signaling as a potential therapeutic strategy for the prevention and treatment of breast cancer. These findings suggest that the lactate-ERK/STAT3 signaling pathway is a driver of breast cancer progression by stimulating macrophage M2-like polarization and reveal potential new therapeutic targets for breast cancer treatment.
Keywords:
Lactate; M2 macrophage polarization; STAT3-ERK1/2 signaling; angiogenesis; breast cancer.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Breast Neoplasms / drug therapy
-
Breast Neoplasms / metabolism
-
Breast Neoplasms / pathology
-
Cell Line, Tumor
-
Cell Movement / drug effects
-
Cell Proliferation / drug effects
-
Extracellular Signal-Regulated MAP Kinases / genetics
-
Extracellular Signal-Regulated MAP Kinases / metabolism*
-
Female
-
Humans
-
Lactic Acid / pharmacology*
-
Macrophages / cytology
-
Macrophages / drug effects
-
Macrophages / metabolism*
-
Membrane Glycoproteins
-
Mice
-
Mice, Inbred BALB C
-
Mice, Nude
-
Phosphorylation / drug effects
-
Receptors, Immunologic / genetics
-
Receptors, Immunologic / metabolism
-
STAT3 Transcription Factor / genetics
-
STAT3 Transcription Factor / metabolism*
-
Signal Transduction / drug effects*
-
Tumor Microenvironment
-
Withanolides / pharmacology
-
Withanolides / therapeutic use
Substances
-
MRC1 protein, human
-
Membrane Glycoproteins
-
Receptors, Immunologic
-
STAT3 Transcription Factor
-
Withanolides
-
withanolide D
-
Lactic Acid
-
Extracellular Signal-Regulated MAP Kinases
Grants and funding
This work was supported by the Jiangsu Provincial Natural Science Foundation [grant number BK20141488]; Jiangsu Province's Key Provincial Talents Program [grant number QNRC2016680]; Projects of medical and health technology development program in Nanjing city [grant number 201715014]; Jiangsu Provincial Innovation Team Program Foundation [grant number 2015ToQY]; Jiangsu Provincial 333 high level talents Program Foundation [grant number CRA2016525]; Jiangsu Provincial Six talent Peaks Program Foundation [grant number 2015-WSW-010]; Jiangsu Provincial Distinguished Medical Experts Program Foundation [grant number 2014ToQY]; Preventive Medicine Foundation of Jiangsu Provincial Commission of Health and Family Planning [grant number Y2013058]; National Natural Science Foundation of China [grant number 81471543], [grant number 81402204], [grant number 81671543]